What may indicate poor management of anemia in dialysis patients?

In the context of dialysis patients, increased fatigue levels can indeed indicate poor management of anemia. Anemia is a common complication in patients undergoing dialysis, often stemming from factors like erythropoietin deficiency, iron deficiency, or chronic inflammation. When anemia is not effectively managed, patients may experience symptoms such as fatigue, weakness, and decreased exercise tolerance, all of which largely stem from insufficient oxygen delivery to tissues due to low hemoglobin levels.

Increased fatigue is a significant sign that the patient's hemoglobin levels may be inadequate and that their anemia is not being well controlled. This fatigue can impair quality of life and limit engagement in daily activities, highlighting the importance of addressing anemia through proper management strategies, which may include iron supplementation or erythropoiesis-stimulating agents.

While other options may reflect different aspects of a patient’s health status, they do not specifically indicate poor management of anemia as clearly as increased fatigue does. For example, stable hemoglobin levels would typically suggest that the patient’s anemia is being well-managed, rather than poorly managed.